| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/14/2005 | EP1572881A2 Tacis and br3 polypeptides and uses thereof |
| 09/14/2005 | EP1572879A2 Method of producing region-specific neurons from human neuronal stem cells |
| 09/14/2005 | EP1572878A2 Compositions and methods for inferring a response to a statin |
| 09/14/2005 | EP1572876A2 Transcriptional regulation of target genes |
| 09/14/2005 | EP1572875A2 Receptors and membrane-associated proteins |
| 09/14/2005 | EP1572874A2 Antibodies that immunospecifically bind to trail receptors |
| 09/14/2005 | EP1572872A2 Igs as modifiers of the p53 pathway and methods of use |
| 09/14/2005 | EP1572871A2 T1r3 a novel taste receptor |
| 09/14/2005 | EP1572870A2 Molecular sequence of pig endogenous retrovirus receptors and methods of use |
| 09/14/2005 | EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 09/14/2005 | EP1572867A2 Endothelial cell expression patterns |
| 09/14/2005 | EP1572866A2 Insect nuclear receptor genes and uses thereof |
| 09/14/2005 | EP1572864A2 Human serpin polypeptides |
| 09/14/2005 | EP1572862A2 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 09/14/2005 | EP1572228A2 Method of inducing maturation of dendritic cells and uses therefor |
| 09/14/2005 | EP1572130A2 Compositions and methods for the treatment of immune related diseases |
| 09/14/2005 | EP1572106A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 09/14/2005 | EP1572094A2 Sodium channel alpha subunit variants |
| 09/14/2005 | EP1572089A2 Method for growing human organs, treating diseases, and increasing longevity |
| 09/14/2005 | EP1572081A2 Live cell method for observing cellular processes |
| 09/14/2005 | EP1572073A2 Alteration of rab38 function to modulate mammalian pigmentation |
| 09/14/2005 | EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells |
| 09/14/2005 | EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/14/2005 | EP1571968A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/14/2005 | EP1571910A2 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 09/14/2005 | EP1390062A4 Modulators of elastase inhibitor secretion |
| 09/14/2005 | EP1255774B1 Methods for identifying compounds useful for the treatment of obesity involving foxc2 |
| 09/14/2005 | EP1198488B1 Biodegradable block copolymers with modifiable surface |
| 09/14/2005 | EP1082141B1 Cd40 binding antibodies and ctl peptides for treating tumors |
| 09/14/2005 | EP1066395B1 Inducible alphaviral gene expression system |
| 09/14/2005 | EP1030676B1 Bonding of cartilaginous matrices using isolated chondrocytes |
| 09/14/2005 | EP0988384B1 New beta-glucanase from a bacillus |
| 09/14/2005 | EP0833933B1 A vector and method for producing influenza hemagglutinin |
| 09/14/2005 | EP0811070B1 Method to obtain male-sterile plants |
| 09/14/2005 | CN1668754A Carotene synthase gene and uses therefor |
| 09/14/2005 | CN1668751A Modified adenovirus vectors for use in vaccines and gene therapy |
| 09/14/2005 | CN1668746A MUC-1 antigen with reduced number of VNTR repeat units |
| 09/14/2005 | CN1668745A transgenic animal for expressing |
| 09/14/2005 | CN1668736A GM-negative EHV-mutants without heterologous elements |
| 09/14/2005 | CN1668735A Method of utilizing physiological activity of rare saccharide and compositions containing rare saccharide |
| 09/14/2005 | CN1668734A Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 09/14/2005 | CN1668733A Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 09/14/2005 | CN1668731A Genetically modified microorganisms, plasmid and fermentation process with the presence of flocculation regulated by medium changes |
| 09/14/2005 | CN1668641A 截短tau蛋白 Truncated tau protein |
| 09/14/2005 | CN1668634A Detection of secreted polypeptides |
| 09/14/2005 | CN1668324A Methods, compositions, and growth and differentiation factors for insulin-producing cells |
| 09/14/2005 | CN1668187A Transgenic ungulates capable of human antibody production |
| 09/14/2005 | CN1667119A Adult stem cell and its culturing method and use |
| 09/14/2005 | CN1667118A Method for separating XY germ cell of mammal |
| 09/14/2005 | CN1667117A Method for in vitro culturing dandelion root and its special differentiation culture medium |
| 09/14/2005 | CN1219064C Plant fatty acid desaturase promoters |
| 09/14/2005 | CN1219062C Mouse cholesterol ester synthetase-2 gene promotor |
| 09/14/2005 | CN1219061C Use of orychophragmus violaceus ODREB2B gene for cultivating drought-tolerant plant |
| 09/14/2005 | CN1219059C Rice flavamonocell hrf2 gene, recombinant vector and method for transgenic breeding plant therefor |
| 09/14/2005 | CN1219053C Allogenic tissue engineered cartilage and its application |
| 09/14/2005 | CN1218961C Osteoclast formation inhibitive factor, its nucleotide sequence and preparation method |
| 09/14/2005 | CN1218959C Paddy rice ethylene receptor protein, coded gene and use thereof |
| 09/14/2005 | CN1218755C Stem cell regenerating surface cornea and its application in corneal transplantation |
| 09/14/2005 | CN1218626C Improved process for cultivation of algae |
| 09/13/2005 | US6943246 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof |
| 09/13/2005 | US6943243 Control of gene expression in eukaryotic cells |
| 09/13/2005 | US6943241 Full-length cDNA |
| 09/13/2005 | US6943240 Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist |
| 09/13/2005 | US6943239 Antigenic fusionprotein carrying Galα1,3Gal epitopes |
| 09/13/2005 | US6943238 Antibodies to cyclin E2 protein |
| 09/13/2005 | US6943150 Antiapoptosis polypeptides or fusion proteins coded by nucleic acids |
| 09/13/2005 | US6943146 Control cell proliferation, cell differentiation; culture product |
| 09/13/2005 | US6943026 A mixture of first and second nucleic acid constructs, is used for gene therapy, as antitumor agents, antiproliferative agents, suppressed by a wild-type p53 allele in non-tumour cells relative to tumor cells, prodrug activating thymidine kinase |
| 09/13/2005 | US6943024 A medium comprising serum, antibiotics, growth factors like hepatocyte growth factor, and epinephrine, for culturing the patient's skin in vitro to generate cell proliferation, migration behaviors and melanin production; treating skin disorder |
| 09/13/2005 | US6943023 Insect cell primary culture medium, extra cellular matrix, and process of preparing an insect culture cell line in a short period of time using the medium and matrix |
| 09/13/2005 | US6943021 Three dimensional vaginal tissue model containing immune cells |
| 09/13/2005 | US6943020 Death domain containing receptor-4 antibodies |
| 09/13/2005 | US6943016 incubating a mixture of astrocytes and glial cells from patient surgical resection, culturing, astrocytes joining to the culture vessel, removing the un-attached cells; purification; treating CNS trauma, neurodegenerative disorders |
| 09/13/2005 | US6943014 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta |
| 09/13/2005 | US6943013 DNA expression vector; host cell transformed, transfected or infected with the vector; transgenic cell, tissue or organism; HCDS1 protein |
| 09/13/2005 | US6943012 Helper dependent adenoviral vector system and methods for using the same |
| 09/13/2005 | US6943008 Chamber has channels for conducting fluids, cell support scaffolds positioning between channels, comprising three-dimensional porous non woven fibrous polyethylene terephthalate matrix, for fluid flow, and cells penetration; biological apparatus |
| 09/13/2005 | US6943000 Detection of modulator of enzyme activity; obtain cells, incubate with modulator, monitor adjustment in enzyme activity, adjustment in activity indicates modulator |
| 09/13/2005 | US6942995 Expression vector for use as tool in genome analysis |
| 09/13/2005 | US6942994 Lyases; plastidic synthetases; pyruvate dehydrogenase/ decarboxylase, aldehyde dehydrogenase; fatty acid biosynthesis; chloroplast photochemistry |
| 09/13/2005 | US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 09/13/2005 | US6942990 Glutaryl cephalosporin amidase from Pseudomonas diminuta BS-203 |
| 09/13/2005 | US6942983 An isolated monoclonal antibody is used for binding and detecting a polypeptide having amino acid sequence with valine at residue 835, modulate kinase activity in cells, protein kinase C |
| 09/13/2005 | US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel |
| 09/13/2005 | US6942965 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
| 09/13/2005 | US6942879 Cells seeded hollow fibers; ultrafiltration |
| 09/13/2005 | US6942873 Biocompatible membrane for use in the growth of muscle cells |
| 09/13/2005 | US6942863 Polypeptide for use the prevention of infections associated with tissue grafting |
| 09/13/2005 | US6942859 Adjusting viscosity |
| 09/13/2005 | US6942853 Latent fusion protein |
| 09/13/2005 | US6942639 Autologous platelet gel delivery system |
| 09/13/2005 | CA2186164C Methods for producing cytoplasmic male sterility in plants and use thereof in production of hybrid seed |
| 09/13/2005 | CA2175476C Opioid receptor: compositions and methods |
| 09/12/2005 | CA2497799A1 Acetolactate synthase gene promoter |
| 09/09/2005 | WO2005083427A1 A method of assaying specification of lymphocyte activation |
| 09/09/2005 | WO2005083097A1 A method for creating myeloid cell lines |
| 09/09/2005 | WO2005083087A1 Transgennic animal allowing inductive deletion of osteocytes |
| 09/09/2005 | WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof |
| 09/09/2005 | WO2005083074A1 Tumor antigen peptides |
| 09/09/2005 | WO2005083064A1 Cancerous disease modifying antibodies |